Checkpoint Therapeutics Inc (CKPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CKPT | AMGN | VRTX | BMY | GILD |
| Company | Checkpoint Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 3.81 | 291.50 | 478.56 | 58.16 | 91.71 |
| High | 3.93 | 291.50 | 479.94 | 58.36 | 91.99 |
| Low | 3.42 | 279.62 | 458.10 | 55.82 | 88.21 |
| Last | 3.41 | 283.62 | 465.70 | 56.23 | 88.47 |
| Change | -0.37 | -12.31 | -18.26 | -2.27 | -3.64 |
| % Change | -9.79% | -4.16% | -3.77% | -3.88% | -3.95% |
| Volume | 969,351 | 4,274,788 | 1,976,946 | 18,435,695 | 7,413,341 |
| 20-Day Average Volume | 1,200,432 | 2,435,089 | 1,150,000 | 11,297,745 | 7,060,656 |
| Previous Close | 3.78 | 295.93 | 483.96 | 58.50 | 92.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.47 | 313.93 | 483.00 | 54.90 | 90.68 |
| 20-Day Raw Stochastic | 45.47% | 7.64% | 7.31% | 44.82% | 20.75% |
| 20-Day Relative Strength | 57.05% | 28.42% | 43.88% | 55.79% | 50.39% |
| Weighted Alpha | +127.88 | -1.32 | +23.41 | +17.82 | +23.57 |
| Today's Opinion | 88% Buy | 40% Sell | 16% Buy | 100% Buy | 80% Buy |
| Previous Opinion | 100% Buy | 40% Sell | 72% Buy | 100% Buy | 96% Buy |
| Last Month's Opinion | 100% Buy | 24% Buy | 56% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.79% since 11/08/24 | -12.90% since 11/08/24 | -10.47% since 11/08/24 | +3.37% since 11/08/24 | -8.50% since 11/08/24 |
| Low | 3.09 on 11/11/24 | 279.62 on 11/15/24 | 458.10 on 11/15/24 | 55.82 on 11/15/24 | 88.35 on 11/15/24 |
| High | 3.95 on 11/14/24 | 327.58 on 11/11/24 | 518.35 on 11/11/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 1-Month | |||||
| %Chg | +29.93% since 10/15/24 | -12.84% since 10/15/24 | -4.48% since 10/15/24 | +6.07% since 10/15/24 | +2.96% since 10/15/24 |
| Low | 2.65 on 10/16/24 | 279.62 on 11/15/24 | 458.10 on 11/15/24 | 51.81 on 10/28/24 | 85.60 on 10/22/24 |
| High | 3.97 on 10/30/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +53.82% since 08/15/24 | -12.92% since 08/15/24 | -1.99% since 08/15/24 | +13.96% since 08/15/24 | +18.86% since 08/15/24 |
| Low | 2.06 on 09/10/24 | 279.62 on 11/15/24 | 447.70 on 10/07/24 | 46.88 on 08/22/24 | 72.89 on 08/16/24 |
| High | 3.97 on 10/30/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +110.44% since 05/15/24 | -11.19% since 05/15/24 | +5.74% since 05/15/24 | +25.62% since 05/15/24 | +31.86% since 05/15/24 |
| Low | 1.60 on 05/16/24 | 279.62 on 11/15/24 | 432.22 on 05/16/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 3.97 on 10/30/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 170,168 | 159,072,144 | 124,633,728 | 118,648,352 | 114,793,560 |
| Shares Outstanding, K | 45,018 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 100,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -51,850,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 40,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -6,670,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 1.23 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.23 on 11/12/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/11/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.68 | 0.00 | 49.92 | 20.91 |